Inhibin is a hormone made mainly by cells in the ovaries and testicles. Pathologists test for inhibin in tissue to help identify certain tumors. Inhibin is most useful for diagnosing sex cord-stromal tumors of the ovary and testicle. It also helps with tumors of the adrenal gland and a few other tumors.
This article explains what inhibin is, how pathologists test for it, which tumors are positive, and what a positive or negative inhibin result means.
Inhibin is a protein hormone that helps control the reproductive system. It signals the pituitary gland in the brain to make less follicle-stimulating hormone (FSH). FSH helps eggs mature in the ovaries and sperm develop in the testicles.
Several types of normal cells make inhibin:
Pathologists test for inhibin using immunohistochemistry. This test uses an antibody that sticks to inhibin in a thin slice of tissue. Cells that contain inhibin turn brown under the microscope. The pathologist then decides whether the tumor cells are positive or negative.
Inhibin testing is a diagnostic test. It helps identify the tumor type. It does not predict whether a treatment will work.
Tumors that start from inhibin-producing cells are usually positive for inhibin. These include:
Most common cancers, such as carcinomas of the breast, colon, or lung, are usually negative. Some of them show weak staining in a few cells.
Pathologists rarely rely on inhibin alone. A small number of unrelated tumors can show some inhibin staining. For this reason, inhibin is usually part of a panel of tests.
For a possible sex cord-stromal tumor, the panel often includes calretinin, SF-1, and FOXL2. Together, these markers make the diagnosis more reliable.
An inhibin result helps the pathologist narrow down the tumor type. Your report may describe the result in these ways:
A positive inhibin result does not mean that a tumor is cancer. Many inhibin-positive tumors, such as Leydig cell tumors and adrenal cortical adenomas, are usually noncancerous.
A laboratory can also measure inhibin in a blood sample. Doctors sometimes use a blood inhibin test to follow people treated for an adult granulosa cell tumor. A rising level can be an early sign that the tumor has come back. This blood test is separate from the inhibin test performed on tissue.
🔍 Search MyPathologyReport
Type what you see on your report — for example a diagnosis or test name